Theravance Biopharma (TBPH) Misses Q2 EPS by 1c

August 8, 2016 4:44 PM EDT
Get Alerts TBPH Hot Sheet
Trade TBPH Now!
Join SI Premium – FREE

Get the Pulse of the Market with StreetInsider.com's Pulse Picks. Get your Free Trial here.

Theravance Biopharma (NASDAQ: TBPH) reported Q2 EPS of ($1.06), $0.01 worse than the analyst estimate of ($1.05).

For earnings history and earnings-related data on Theravance Biopharma (TBPH) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Earnings

Related Entities

Earnings

Add Your Comment